Patton Cynthia M 4
4 · AMGEN INC · Filed May 7, 2020
Insider Transaction Report
Form 4
AMGEN INCAMGN
Patton Cynthia M
SVP & CCO
Transactions
- Award
Common Stock
2020-05-05+676→ 24,751 total - Award
Nqso (Right to Buy)
2020-05-05+5,668→ 5,668 totalExercise: $236.36From: 2022-05-05Exp: 2030-05-05→ Common Stock (5,668 underlying)
Holdings
- 270.044(indirect: By 401(k))
Common Stock
Footnotes (5)
- [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/5/2022, 5/5/2023 and 5/5/2024, respectively.
- [F2]These shares include the following RSUs granted under the Company's equity plans: 335 RSUs which vest on 5/1/2021; 604 RSUs which vest in installments of 297 on 4/27/2021 and 307 on 4/27/2022; 902 RSUs which will vest in installments of 297 on 5/3/2021, 298 on 5/3/2022 and 307 on 5/3/2023; and 676 RSUs which vest in two installments of 223 on 5/5/2022 and 5/5/2023, and one installment of 230 on 5/5/2024.. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F3]These shares include 93 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
- [F4]These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
- [F5]These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/5/2022, 5/5/2023 and 5/5/2024, respectively.